ライフサイエンスコーパス: killer immunoglobulin-like receptor

1 mat, and cell surface receptors, such as the killer immunoglobulin-like receptors.

2 pecifically downregulates disease-associated killer immunoglobulin-like receptors.

3 els of the activating receptor NKp46 and the killer immunoglobulin-like receptors 2DL1/S1 and 3DL1, r

4 cytolytic function associated with decreased killer immunoglobulin-like receptor 3DL1 expression.

5 CD117(+)M-CSFR(+)) showed more expression of killer immunoglobulin-like receptors, a fraction of kill

6 tural killer (NK) cells and their activating killer immunoglobulin-like receptors (aKIRs) influence t

7 rtain the association of natural killer cell killer immunoglobulin-like receptors and human leukocyte

8 ike receptors, mannose-binding lectin, CD14, killer immunoglobulin-like receptors, and matrix metallo

9 e-binding positions 9, 99, 116, and 156, and killer immunoglobulin-like receptor binding position 77

10 sion is closely monitored by NK cells, whose killer immunoglobulin-like receptors encode MHC-I-specif

11 ng patients (n=222) and controls (n=191) for killer immunoglobulin-like receptor gene polymorphisms d

12 g/m(2)/d on days -6 through -2), followed by killer immunoglobulin-like receptor-human leukocyte anti

13 regard, NK cells that express an inhibitory killer immunoglobulin-like receptor (iKIR) for which the

14 ating natural killer (NK) cell receptor, the killer immunoglobulin-like receptor (KIR) 3DS1, and its

15 ells expressing CD94: NKG2A but no change in killer immunoglobulin-like receptor (KIR) expression.

16 The killer immunoglobulin-like receptor (KIR) gene cluster s

17 in reaction (PCR) assays to compare NKG2 and killer immunoglobulin-like receptor (KIR) gene expressio

18 -cells played by the inherited repertoire of killer immunoglobulin-like receptor (KIR) genes therefor

19 Killer immunoglobulin-like receptor (KIR) genes vary con

20 atural killer (NK) receptors, in particular, killer immunoglobulin-like receptor (KIR) KIR3DL2, a rec

21 ent MHC class I ligands for donor inhibitory killer immunoglobulin-like receptor (KIR) receptors, as

22 Killer immunoglobulin-like receptor (KIR) recognition of

23 Furthermore, killer immunoglobulin-like receptor (KIR)/KIR-ligand mis

24 " In humans, interactions between inhibitory killer immunoglobulin-like receptors (KIR) and human MHC

25 Killer immunoglobulin-like receptors (KIR) are expressed

26 Killer immunoglobulin-like receptors (KIR) bind self-maj

27 een HLA-B27 and immune receptors such as the killer immunoglobulin-like receptors (KIR) found on a ra

28 are transmitted by NK inhibitory receptors (killer immunoglobulin-like receptors, KIR) at the site o

29 Interactions between killer immunoglobulin-like receptors (KIRs) and human le

30 ct to two such families of NK receptors, the killer immunoglobulin-like receptors (KIRs) and the kill

31 Killer immunoglobulin-like receptors (KIRs) are a family

32 I molecules as ligands to NK cell inhibitory killer immunoglobulin-like receptors (KIRs) as a means o

33 Killer immunoglobulin-like receptors (KIRs) bind human l

34 city is attenuated by ligation of inhibitory killer immunoglobulin-like receptors (KIRs) by HLA class

35 portant role of NK cells expressing specific killer immunoglobulin-like receptors (KIRs) in the contr

36 Cellular inactivation through killer immunoglobulin-like receptors (KIRs) may allow ne

37 Killer immunoglobulin-like receptors (KIRs) on natural k

38 Receptors termed killer immunoglobulin-like receptors (KIRs) on NK cells

39 The killer immunoglobulin-like receptors (KIRs) on NK cells

40 argely been attributed to mismatches between killer immunoglobulin-like receptors (KIRs) on NK cells

41 Killer immunoglobulin-like receptors (KIRs) play an esse

42 Killer immunoglobulin-like receptors (KIRs) regulate cel

43 Killer immunoglobulin-like receptors (KIRs) regulate nat

44 ansplantation, produce cytokines and express killer immunoglobulin-like receptors (KIRs) that regulat

45 h increasing age, T cells gain expression of killer immunoglobulin-like receptors (KIRs) that transmi

46 Instead, CD4(+)CD28(null) T cells express killer immunoglobulin-like receptors (KIRs) with a prefe

47 ors, including the activating and inhibitory killer immunoglobulin-like receptors (KIRs), and human l

48 tural killer (NK) cells possess little or no killer immunoglobulin-like receptors (KIRs), high interf

49 cted cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs).

50 ler (NK) cells and these share expression of killer immunoglobulin-like receptors (KIRs).

51 yndromes (ACS), CD4+CD28null T cells express killer immunoglobulin-like receptors (KIRs).

52 ulations that clonally expressed one or more killer immunoglobulin-like receptors (KIRs).

53 ic factors for improved outcome were missing killer immunoglobulin-like receptor ligand (PFS and OS),

54 ng CBRM1/5-positive granulocytes and missing killer immunoglobulin-like receptor ligand as positive i

55 When the model for OS also included missing killer immunoglobulin-like receptor ligand, human antimo

56 Stimulatory killer immunoglobulin-like receptors, NKG2D and stimulat

57 Since Cw*04 is a ligand for the killer immunoglobulin-like receptors on natural killer c

58 immunoglobulin-like receptors, a fraction of killer immunoglobulin-like receptor-positive-expressing